Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with cancer in the head and neck area, specifically in the mouth, throat, voice box, or the area just below the throat (with a tumour stage ranging from T1 to T4)
- People who are receiving their cancer care at Thomas Jefferson University – Center City, treated by a surgeon who has completed specialist fellowship training in head and neck cancer
- People whose cancer is suitable for surgery aimed at fully removing the tumour
- People who are over 18 years of age
- People who are willing and able to sign a written consent form to take part in the study
Who may not be able to join:
- People who have difficulty making decisions or who are not able to give informed consent on their own
- People who have any condition or circumstance that could put them at greater risk of harm, or that might prevent them from fully completing the study (confirm with trial site)
- People who have been diagnosed with nasopharyngeal carcinoma, which is a specific type of cancer at the back of the nose and throat
- People for whom surgery is medically not safe or not recommended
- People who are already taking part in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 215-955-6784
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Margin events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.